Medicare Part D coverage · fluticasone propionate · RxCUI 1946589
fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance]
Per the CMS 2026 Part D formulary file, fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] is covered by 1,669 Medicare Part D plans (33% of enrollable products), averaging Tier 3.4, with prior authorization required on 66.3% of covering formularies.
- 33%
- Plan coverage
- 1,669
- Plans covering
- T3.4
- Avg tier
- 66.3%
- Prior auth required
What the CMS Formulary Data Shows for fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance]
Per the CMS 2026 Part D formulary file, fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] (RxNorm concept RXCUI 1946589, generic name fluticasone propionate) appears on 104 distinct formulary files spanning 1,669 Medicare Part D plan offerings - 33% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.4.
Real-world access to fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] depends on utilization management as much as tier placement: 66.3% of covering formularies require prior authorization. 14.4% require step therapy. 88.5% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 4,902,813 Part D beneficiaries filled fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] in 2023, with total plan-and-beneficiary spending of $201,536,224 and an average per-beneficiary annual cost of $41.11. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] today.
Coverage Details
- Formularies covering
- 104
- Plans covering
- 1,669
- Coverage rate
- 33%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 66.3% of formularies
- Step therapy required
- 14.4% of formularies
- Quantity limits
- 88.5% of formularies
2023 Medicare Spending
- Beneficiaries
- 4,902,813
- Total spending
- $201,536,224
- Avg per beneficiary
- $41.11
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $0 | FL |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | Yes | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | Yes | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | Yes | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | Yes | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | Yes | $0 | NY |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | No | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | No | $0 | MN |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
Show the next 30 plans
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | Yes | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $0 | DE |
| Florida Complete Care (HMO I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Florida Complete Care- In The Community (HMO-POS I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | No | $4.80 | TX |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS Insurance Company | T1 | No | $5.00 | OK |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $13.10 | PA |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $17.60 | PA |
| Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $22.70 | NY |
| VIVA Medicare Extra Value (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
| VIVA Medicare Extra Care (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
| Highmark Health Options Duals Select (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $31.20 | DE |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $34.50 | NY |
| Elderplan Advantage For Nursing Home Residents (HMO-POS I-SNP) | Elderplan, Inc. | T1 | Yes | $44.80 | NY |
| MetroPlus Platinum Plan (HMO) | Metroplus Health Plan, Inc. | T1 | Yes | $58.80 | NY |
| Leon MediExtra (HMO) | Leon Health, Inc. | T2 | No | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T2 | No | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T2 | No | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T2 | No | $0 | FL |
| BlueCare Plus (HMO D-SNP) | Volunteer State Health Plan | T3 | Yes | $0 | TN |
| BlueCare Plus Choice (HMO D-SNP) | Volunteer State Health Plan | T3 | Yes | $0 | TN |
| BlueCare Plus Select (HMO D-SNP) | Volunteer State Health Plan | T3 | Yes | $0 | TN |
| Prominence Plus (HMO) | Prominence Healthfirst | T3 | No | $0 | NV |
| Prominence Plus (HMO) | Prominence Healthfirst | T3 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst | T3 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst | T3 | No | $0 | NV |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] covered by Medicare Part D?
Yes, fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] is covered by 1,669 Medicare Part D plans (33% of all Part D formularies).
What tier is fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] on Medicare Part D plans?
fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] averages Tier 3.4 across Part D plans, ranging from Tier 1 to Tier 4.
Does fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] require prior authorization?
66.3% of Part D formularies require prior authorization for fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance]. Step therapy: 14.4%. Quantity limits: 88.5%.
How much does Medicare spend on fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance]?
In 2023, total Medicare Part D spending on fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance] was $201,536,224, covering 4,902,813 beneficiaries. The average spend per beneficiary was $41.11.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- {14 (cenobamate 12.5 MG Oral Tablet [Xcopri]) / 14 (cenobamate 25 MG Oral Tablet [Xcopri]) } Pack [Xcopri Titration Pack - 12.5 MG (14), 25 MG (14) 28 Count] T3.4
- {2 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 4 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack] T3.4
- Sprinkle duloxetine 20 MG Delayed Release Oral Capsule [Drizalma] T3.4
- Sprinkle duloxetine 40 MG Delayed Release Oral Capsule [Drizalma] T3.4
- methotrexate 2.5 MG/ML Oral Solution [Xatmep] T3.4
- 0.4 ML darbepoetin alfa 0.1 MG/ML Prefilled Syringe [Aranesp] T3.4
Similar prior-authorization rate
- 0.6 ML methylnaltrexone bromide 20 MG/ML Prefilled Syringe [Relistor] 66.4% PA
- tazarotene 1 MG/ML Topical Cream 66.5% PA
- miltefosine 50 MG Oral Capsule [Impavido] 65.9% PA
- meperidine hydrochloride 10 MG/ML Oral Solution 66.7% PA
- tretinoin 0.25 MG/ML Topical Cream [Retin-A] 66.7% PA
- 1 ML meperidine hydrochloride 25 MG/ML Injection 66.7% PA